CA Patent

CA2254060A1 — Effervescent bisphosphonate formulation

Assigned to Merck Sharp and Dohme LLC · Expires 1997-11-27 · 28y expired

What this patent protects

An effervescent formulation of alendronate contains an acid source, a carbonate source, a binder, a lubricant and, optionally, flavoring agents, colorants and sweeteners.

USPTO Abstract

An effervescent formulation of alendronate contains an acid source, a carbonate source, a binder, a lubricant and, optionally, flavoring agents, colorants and sweeteners.

Drugs covered by this patent

Patent Metadata

Patent number
CA2254060A1
Jurisdiction
CA
Classification
—
Expires
1997-11-27
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.